utic Potential of Stem Cells in Neurodegenerative Diseases

67

H. Choi, Y. H. Kim, M. Hebisch, et al., “A three-dimensional hu-

an neural cell culture model of alzheimer’s disease,” Nature, vol. 515,

p. 274–278, 11 2014.

M. Hossini, M. Megges, A. Prigione, et al., “Induced pluripotent stem

ll-derived neuronal cells from a sporadic alzheimer’s disease donor as a

odel for investigating ad-associated gene regulatory networks,” BMC

enomics, vol. 16, p. 84, 12 2015.

van der Kant, V. F. Langness, C. M. Herrera, et al., “Cholesterol

etabolism is a druggable axis that independently regulates tau and

myloid-β in ipsc-derived alzheimer’s disease neurons,” Cell Stem Cell,

l. 24, pp. 363–375.e9, 3 2019.

Arber, C. Lovejoy, and S. Wray, “Stem cell models of alzheimer’s

sease: progress and challenges,” Alzheimer’s Research and Therapy,

l. 9, p. 42, 12 2017.

Fanizza, L. Boeri, F. Donnaloja, et al., “Development of an induced

uripotent stem cell-based liver-on-a-chip assessed with an alzheimer’s

sease drug,” ACS Biomaterials Science and Engineering, vol. 9,

p. 4415–4430, 7 2023.

Kondo, K. Imamura, M. Funayama, et al., “ipsc-based compound

reening and in vitro trials identify a synergistic anti-amyloid β com-

nation for alzheimer’s disease,” Cell Reports, vol. 21, pp. 2304–2312,

2017.

Park, J. Kim, and C. Ryou, “A three‐dimensional spheroid co‐culture

stem of neurons and astrocytes derived from alzheimer’s disease pa-

ents for drug efficacy testing,” Cell Proliferation, vol. 56, 6 2023.

-C. Park, S.-Y. Jang, D. Lee, et al., “A logical network-based drug-

reening platform for alzheimer’s disease representing pathological fea-

res of human brain organoids,” Nature Communications, vol. 12,

280, 1 2021.

Williams, A. Gatt, E. Clarke, et al., “Drug repurposing for

zheimer’s disease based on transcriptional profiling of human ipsc-

rived cortical neurons,” Translational Psychiatry, vol. 9, p. 220, 9

19.

Fujiwara, J. Shimizu, K. Takai, et al., “Cellular and molecular mech-

isms of the restoration of human app transgenic mouse cognitive dys-

nction after transplant of human ips cell-derived neural cells,” Exper-

mental Neurology, vol. 271, pp. 423–431, 9 2015.